New Horizon Medical Solutions (NHMS), a leader in advanced wound care technologies, has announced a strategic collaboration with Soring, the U.S. affiliate of Söring (Germany), for the sale of the SONOCA 185 Ultrasonic-Assisted Wound (UAW) debridement system. This partnership aims to enhance wound treatment across various medical settings by integrating ultrasonic debridement with NHMS's portfolio of biologically derived human placental allograft products.
The SONOCA 185 system, comprising an ultrasonic generator and instrument, is designed for debridement and cleansing of chronic and acute wounds. It removes fibrin tissues such as necroses, fibrin, scab, and pus, and disrupts biofilms, thereby improving wound status and promoting healing in conditions like diabetic foot syndrome, decubitus ulcers, burns, and post-surgical or post-traumatic wounds.
Jeffrey Alan Niezgoda, MD, FACHM, MAPWCA, CHWS, Chief Medical Officer of Kent Imaging and board member of NHMS, highlighted the synergistic benefits: "The use of SONOCA 185 and the UAW instruments for Ultrasonic Wound Debridement guided by SnapshotGLO and monitored by SnapshotNIR, can significantly improve wound management and lead to better patient outcomes. These devices synergistically optimize wound bed preparation prior to CAMPs application."
Will Hall, CEO of New Horizon Medical Solutions, emphasized the strategic importance: "This collaboration reflects our belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions. By bringing Söring's ultrasonic system into our portfolio, we're expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings."
The collaboration is expected to improve wound bed preparation, which is crucial for the effectiveness of advanced wound care products like placental allografts. NHMS offers a range of products including amniotic membranes, placental tissues, and skin grafts for chronic wounds, surgical reconstruction, burns, and orthopedic procedures. Söring, founded in 1985 and headquartered in Germany, specializes in ultrasonic tissue resection and ablation, with a focus on intuitive user experience and direct service.
This partnership underscores a trend toward integrating complementary technologies in wound care to address complex healing challenges. For more information, visit www.nhmedical.com.
